Get the SPI Wire

PYXIS ONCOLOGY, INC.

NASDAQ:PYXS
Annual Meeting

of Shareholders

MEETING DATE

11/13/2026
DEF 14A FILED
10/21/2026
PUBLISHED
10/21/2026 8:27 pm
TIME TO PUBLISH
10/23/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:PYXS · CUSIP 747324101 · CLASS Common Stock · CIK 0001782223

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

0
FOR
2
AGAINST
0
WITHHOLD
2
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share from 190,000,000 shares to 380,000,000 shares
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states future issuances could dilute current stockholders’ voting power and could discourage efforts to obtain control.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Approval of one or more adjournments of the Special Meeting to solicit additional proxies, if necessary
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the meeting could be adjourned despite sufficient votes against Proposal One to seek changed votes.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

da24863f292f3e5c703bd3d4127aaf30cea161899427e7023b7de4ef671899a7

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates